Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001042074-13-000003
Filing Date
2013-10-11
Accepted
2013-10-11 15:11:19
Documents
1
Effectiveness Date
2013-10-11
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11532
  Complete submission text file 0001042074-13-000003.txt   12807
Mailing Address 3876 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3876 BAY CENTER PLACE HAYWARD CA 94545 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-204453 | Film No.: 131147851
SIC: 2834 Pharmaceutical Preparations